10-QPeriod: Q1 FY2003

INTUITIVE SURGICAL INC Quarterly Report for Q1 Ended Mar 31, 2003

Filed May 15, 2003For Securities:ISRG

Summary

Intuitive Surgical, Inc. (ISRG) reported its financial results for the quarter ended March 31, 2003. The company generated sales of $19.2 million, a significant 33% increase compared to the same period in the prior year. This growth was primarily driven by an increase in recurring revenue from instruments, accessories, and service, which grew by 103%, and a slight increase in da Vinci Surgical System unit shipments. Despite revenue growth, the company reported a net loss of $2.3 million for the quarter, an improvement from the $5.6 million net loss in the prior year's first quarter. This indicates progress in narrowing losses, but the company remains unprofitable. A major development during the quarter was the announcement of a proposed merger with Computer Motion, Inc. on March 7, 2003. This strategic move aims to combine the two leading robotic surgery companies, with anticipated annual pre-tax cost savings of approximately $18 million. The merger is subject to shareholder approval and is expected to close around June 30, 2003. The company also noted ongoing significant litigation with Brookhill-Wilk 1, LLC and Computer Motion, though proceedings have been stayed pending the merger.

Key Highlights

  • 1Total sales increased by 33% to $19.2 million for the three months ended March 31, 2003, compared to $14.4 million for the same period in 2002.
  • 2Recurring revenue (instruments, accessories, and service) showed strong growth, increasing by 103% to $5.4 million, and now represents 28% of total revenue, up from 19% in the prior year.
  • 3The company shipped 14 da Vinci Surgical Systems in Q1 2003, up from 13 in Q1 2002, bringing the total cumulative shipped systems to 163.
  • 4Gross profit margin improved to 54.6% from 47.9%, attributed to a higher average selling price for the da Vinci system and lower warranty costs.
  • 5Research and development expenses decreased by 19% to $3.4 million, primarily due to lower clinical trial and development project costs.
  • 6Selling, general, and administrative expenses increased by 16% to $10.2 million, largely due to higher litigation costs related to the Computer Motion lawsuit.
  • 7A net loss of $2.3 million ($0.06 per share) was reported for the quarter, an improvement from a net loss of $5.6 million ($0.15 per share) in the prior year's quarter.
  • 8Intuitive Surgical announced a merger agreement with its competitor, Computer Motion, Inc., on March 7, 2003, which is expected to result in significant cost savings and market consolidation.

Frequently Asked Questions

Intuitive Surgical reported a 33% increase in sales to $19.2 million for the quarter ended March 31, 2003, driven by growth in both system shipments and recurring revenue. Despite revenue growth, the company reported a net loss of $2.3 million, though this is an improvement from a $5.6 million loss in the same quarter last year. Gross profit margin also improved.

The proposed merger with Computer Motion is a major strategic event. It aims to combine the two leading companies in the robotic surgery market, which is expected to yield significant cost synergies, estimated at $18 million annually. This merger would consolidate the market and potentially reduce competitive pressures, though it also brings integration challenges and risks.

The company continues to operate at a net loss, although the loss has narrowed year-over-year. Net cash used in operating activities was $5.9 million for the quarter. Management believes current cash and short-term investments, along with projected revenues, will be sufficient to fund operations through 2003. However, the company may need to seek additional financing thereafter. The merger with Computer Motion, which also incurred significant losses, will impact the combined entity's financial profile and liquidity.

Key risks include ongoing intellectual property litigation with Brookhill-Wilk 1, LLC and previously with Computer Motion (now stayed due to the merger). The company also faces risks related to market acceptance of its products, competition, regulatory approvals, supply chain reliance, and potential product liability claims. The merger itself carries integration risks and potential dilution for existing shareholders.